BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.410
-0.015 (-1.05%)
Jul 21, 2026, 9:56 AM EDT - Market open
BioVie Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 13.1 | 17.54 | 23.84 | 19.46 | 18.64 | 4.51 |
Short-Term Investments | - | - | - | 14.48 | - | - |
Cash & Short-Term Investments | 13.1 | 17.54 | 23.84 | 33.94 | 18.64 | 4.51 |
Cash Growth | -43.42% | -26.42% | -29.74% | 82.06% | 313.19% | 12029.69% |
Other Receivables | 2.17 | 2.1 | - | - | - | - |
Total Trade Receivables | 2.17 | 2.1 | - | - | - | - |
Other Current Assets | 1.61 | 1.05 | 0.2 | 0.1 | 0.14 | 0.09 |
Total Current Assets | 16.88 | 20.7 | 24.05 | 34.04 | 18.78 | 4.61 |
Net Property, Plant & Equipment | 0.28 | 0.34 | 0.41 | 0.08 | 0.12 | - |
Other Intangible Assets | 0.01 | 0.18 | 0.41 | 0.64 | 0.87 | 1.1 |
Goodwill | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
Other Long-Term Assets | - | - | - | - | 0 | 1.44 |
Total Assets | 17.51 | 21.56 | 25.21 | 35.1 | 20.11 | 6.05 |
Accounts Payable | 1.61 | 2.2 | 3.59 | 3.48 | 2.44 | 1 |
Current Portion of Long-Term Debt | - | - | 5.7 | 9.11 | - | - |
Current Portion of Leases | 0.08 | 0.07 | 0.06 | 0.04 | 0.04 | - |
Other Current Liabilities | - | - | 0 | 1.87 | 1.69 | - |
Total Current Liabilities | 1.69 | 2.27 | 9.35 | 14.49 | 4.17 | 1 |
Long-Term Debt | - | - | - | 5.23 | 12.14 | - |
Long-Term Leases | 0.21 | 0.28 | 0.35 | 0.04 | 0.09 | - |
Other Long-Term Liabilities | - | - | - | - | 0.05 | - |
Total Long-Term Liabilities | 0.21 | 0.28 | 0.35 | 5.27 | 12.27 | - |
Total Liabilities | 1.91 | 2.55 | 9.7 | 19.76 | 16.44 | 1 |
Common Stock | 0 | 0.01 | 0.01 | 0 | 0 | 0 |
Treasury Stock | -0 | -0 | -0 | -0 | - | - |
Additional Paid-in Capital | 384.22 | 371.15 | 349.73 | 316.39 | 254.64 | 229.93 |
Accumulated Other Comprehensive Income | - | - | - | 0.18 | - | - |
Retained Earnings | -368.62 | -352.14 | -334.23 | -301.23 | -250.97 | -224.89 |
Shareholders' Equity | 15.61 | 19.01 | 15.51 | 15.34 | 3.67 | 5.05 |
Total Liabilities & Equity | 17.51 | 21.56 | 25.21 | 35.1 | 20.11 | 6.05 |
Total Debt | 0.3 | 0.35 | 6.11 | 14.42 | 12.27 | 0 |
Net Cash (Debt) | 12.8 | 17.19 | 17.73 | 19.52 | 6.38 | 4.51 |
Net Cash Growth | -25.54% | -3.03% | -9.15% | 206.10% | 41.34% | - |
Net Cash Per Share | 2.27 | 11.64 | 39.24 | 79.14 | 25.86 | 36.38 |
Book Value | 15.61 | 19.01 | 15.51 | 15.34 | 3.67 | 5.05 |
Book Value Per Share | 2.77 | 12.87 | 34.32 | 62.20 | 14.88 | 40.72 |
Tangible Book Value | 15.26 | 18.49 | 14.75 | 14.36 | 2.46 | 3.61 |
Tangible Book Value Per Share | 2.71 | 12.51 | 32.65 | 58.22 | 9.97 | 29.10 |